Legal & General Group’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $128K | Sell |
46,798
-114,071
| -71% | -$311K | ﹤0.01% | 2626 |
|
|
2025
Q1 | $270K | Sell |
160,869
-308
| -0.2% | -$517 | ﹤0.01% | 2566 |
|
|
2024
Q4 | $263K | Buy |
161,177
+6,797
| +4% | +$11.1K | ﹤0.01% | 2631 |
|
|
2024
Q3 | $642K | Buy |
154,380
+2,876
| +2% | +$12K | ﹤0.01% | 2376 |
|
|
2024
Q2 | $827K | Buy |
151,504
+43,857
| +41% | +$239K | ﹤0.01% | 2257 |
|
|
2024
Q1 | $1.08M | Buy |
107,647
+17,700
| +20% | +$177K | ﹤0.01% | 2167 |
|
|
2023
Q4 | $367K | Hold |
89,947
| – | – | ﹤0.01% | 2568 |
|
|
2023
Q3 | $348K | Sell |
89,947
-874
| -1% | -$3.38K | ﹤0.01% | 2571 |
|
|
2023
Q2 | $541K | Buy |
90,821
+20,812
| +30% | +$124K | ﹤0.01% | 2437 |
|
|
2023
Q1 | $229K | Buy |
70,009
+2,443
| +4% | +$7.99K | ﹤0.01% | 2543 |
|
|
2022
Q4 | $267K | Hold |
67,566
| – | – | ﹤0.01% | 2505 |
|
|
2022
Q3 | $406K | Buy |
67,566
+1,864
| +3% | +$11.2K | ﹤0.01% | 2401 |
|
|
2022
Q2 | $422K | Buy |
65,702
+9,984
| +18% | +$64.1K | ﹤0.01% | 2386 |
|
|
2022
Q1 | $461K | Buy |
55,718
+37,020
| +198% | +$306K | ﹤0.01% | 2415 |
|
|
2021
Q4 | $290K | Buy |
18,698
+9,140
| +96% | +$142K | ﹤0.01% | 2581 |
|
|
2021
Q3 | $215K | Buy |
9,558
+6,096
| +176% | +$137K | ﹤0.01% | 2669 |
|
|
2021
Q2 | $68K | Buy |
3,462
+150
| +5% | +$2.95K | ﹤0.01% | 2863 |
|
|
2021
Q1 | $111K | Buy |
+3,312
| New | +$111K | ﹤0.01% | 2590 |
|